Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice

Kaat De Groot; Diedert Luc De Paep; Ines De Mesmaeker; Krista Suenens; Geert Stange; Zhidong Ling; Bart Keymeulen; Daniel Jacobs-Tulleneers-Thevissen; Danny Pipeleers

Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice

Research output: Unpublished contribution to conference › Poster

Original language	English
Publication status	Published - 14 Sept 2024
Event	European Summer School on Stem Cell Biology and Regenerative Medicine XVII - Spetses, Greece Duration: 13 Sept 2024 → 20 Sept 2024

Workshop

Workshop	European Summer School on Stem Cell Biology and Regenerative Medicine XVII
Country/Territory	Greece
City	Spetses
Period	13/09/24 → 20/09/24

Handle.net

Persistent link

1 Finished
2 Active

SRP96: Biologic Platform for Early Detection, Prevention and Treatment of Type 1 Diabetes
Keymeulen, B. (Administrative Promotor) & Jacobs-Tulleneers-Thevissen, D. (CoI (Co-Promotor))
1/03/24 → 28/02/29
Project: Fundamental
FWOTM1120: Microenvironmental Conditions to Support Formation of Metabolically Adequate Functional Beta Cell Mass by Human Islet Cell implants in the Omentum of Type 1 Diabetes Patients
Jacobs-Tulleneers-Thevissen, D. (Administrative Promotor)
1/10/22 → 30/09/27
Project: Fundamental
FWOTM1011: Biologic Characterization of Stem Cell-Derived Beta Cells Generated from Type 1 Diabetes Patients
De Groot, K. (Mandate) & Jacobs-Tulleneers-Thevissen, D. (Administrative Promotor)
1/11/20 → 1/10/24
Project: Fundamental

Cite this

De Groot, K., De Paep, D. L., De Mesmaeker, I., Suenens, K., Stange, G., Ling, Z., Keymeulen, B., Jacobs-Tulleneers-Thevissen, D., & Pipeleers, D. (2024). Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice. Poster session presented at European Summer School on Stem Cell Biology and Regenerative Medicine XVII, Spetses, Greece.

@conference{54faf8e3951c456abfad58d49a868b12,

title = "Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice",

author = "\{De Groot\}, Kaat and \{De Paep\}, \{Diedert Luc\} and \{De Mesmaeker\}, Ines and Krista Suenens and Geert Stange and Zhidong Ling and Bart Keymeulen and Daniel Jacobs-Tulleneers-Thevissen and Danny Pipeleers",

year = "2024",

month = sep,

day = "14",

language = "English",

note = "European Summer School on Stem Cell Biology and Regenerative Medicine XVII ; Conference date: 13-09-2024 Through 20-09-2024",

}

De Groot, K , De Paep, DL, De Mesmaeker, I, Suenens, K , Stange, G , Ling, Z , Keymeulen, B , Jacobs-Tulleneers-Thevissen, D & Pipeleers, D 2024, 'Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice', European Summer School on Stem Cell Biology and Regenerative Medicine XVII, Spetses, Greece, 13/09/24 - 20/09/24.

Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice. / De Groot, Kaat ; De Paep, Diedert Luc; De Mesmaeker, Ines et al.
2024. Poster session presented at European Summer School on Stem Cell Biology and Regenerative Medicine XVII, Spetses, Greece.

Research output: Unpublished contribution to conference › Poster

TY - CONF

T1 - Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice

AU - De Groot, Kaat

AU - De Paep, Diedert Luc

AU - De Mesmaeker, Ines

AU - Suenens, Krista

AU - Stange, Geert

AU - Ling, Zhidong

AU - Keymeulen, Bart

AU - Jacobs-Tulleneers-Thevissen, Daniel

AU - Pipeleers, Danny

PY - 2024/9/14

Y1 - 2024/9/14

M3 - Poster

T2 - European Summer School on Stem Cell Biology and Regenerative Medicine XVII

Y2 - 13 September 2024 through 20 September 2024

ER -

Conditions for glucose control by implants of human pluripotent stem cell-derived beta cell preparations in mice

Workshop

Handle.net

Projects

SRP96: Biologic Platform for Early Detection, Prevention and Treatment of Type 1 Diabetes

FWOTM1120: Microenvironmental Conditions to Support Formation of Metabolically Adequate Functional Beta Cell Mass by Human Islet Cell implants in the Omentum of Type 1 Diabetes Patients

FWOTM1011: Biologic Characterization of Stem Cell-Derived Beta Cells Generated from Type 1 Diabetes Patients

Cite this